Does Red Light Therapy (LLLT) Actually Regrow Hair?
Analyzing the clinical data behind Low-Level Laser Therapy devices, caps, and helmets for treating androgenetic alopecia.
The Science of Photobiomodulation
Low-Level Laser Therapy (LLLT), officially known as photobiomodulation, uses specific wavelengths of light—typically in the 630 to 670 nanometer (red light) spectrum—to irradiate the scalp.
The proposed mechanism of action involves the absorption of these photons by cytochrome c oxidase within the cellular mitochondria. This absorption is believed to increase ATP (adenosine triphosphate) production, boost cellular metabolism, and increase local blood flow.
By revitalizing the cellular environment, LLLT aims to push resting (telogen) follicles back into the active growth (anagen) phase and prolong the duration of the growth cycle.
Clinical Efficacy vs Reality
Several FDA-cleared devices (caps, helmets, bands) exist on the market. Systematic reviews of LLLT for androgenetic alopecia generally show a statistically significant increase in hair density.
However, expectations must be managed. LLLT is widely considered an excellent *adjunct* therapy. It works best when combined with FDA-approved pharmaceuticals like finasteride (which halts DHT-induced miniaturization) and minoxidil (which aggressively stimulates growth).
Used alone, LLLT may help thicken existing hair or slow shedding, but it is unlikely to resurrect dead follicles or restore a totally bare scalp.